Volume Spike Investor

Pharmacyclics (NASDAQ: PCYC) is a micro-cap biotech that may get overlooked by most because of its size and share price. The stock is surging on a 19% gain to $1.25 today on positive data from Phase I/II non-Hodgkins lymphoma presented at the International Conference on Malignant Lymphoma.

This is a 5-times normal trading volume day as we’ve already seen 334,013 shares trade hands. Its normal daily volume is about 64,500 shares. Its 52-week trading range is $0.55 to $3.28 and its market cap is a mere $32.5 million even after the run.  This is also its most active trading day on share volume for 2008.

You can read the full summary and brief analysis regarding the company’s news, cash position, and more at BioHealthInvestor.com.

Jon Ogg
June 5, 2008